CollPlant Biotechnologies Ltd. reported its financial results for the three months ended March 31, 2025. The company experienced a significant increase in revenues, which rose to $2.055 million compared to $98,000 in the same period the previous year. Despite the increase in revenues, the company reported a net loss of $1.452 million, a notable improvement from the $4.195 million loss reported in the first quarter of 2024. The total operating loss for the quarter was $1.648 million, down from $4.329 million the year prior. This improvement in financial performance is reflected in the non-GAAP net loss, which decreased to $1.130 million from $3.954 million in the previous year. CollPlant's management emphasized that the non-GAAP financial measures provide meaningful supplemental information regarding the company's performance, excluding non-cash expenses related to share-based compensation and changes in operating lease accounts. No specific outlook or guidance for future periods was provided in the release.